Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-11-06
1999-03-30
Weddington, Kevin E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514394, A61K 3141, A61K 31415
Patent
active
058890360
ABSTRACT:
This invention relates to prophylactic or therapeutic drug for diabetic nephropathy or glomerulonephritis, comprising, as an active ingredient, a compound or salt thereof represented by general formula (I) ##STR1## wherein R.sup.1 stands for H or an optionally substituted hydrocarbon residue; R.sup.2 stands for an optionally esterified carboxyl group; R.sup.3 stands for a group actually or potentially capable of forming an anion; X shows that the phenylene and phenyl groups bind to each other directly or through a spacer having an atomic chain length of two or less; n stands for 1 or 2; ring A stands for a benzene ring having an optional substituent in addition to R.sup.2 ; Y stands for a bond, --O--, --S(O).sub.m -- (wherein m stands for 0, 1 or 2), or --N(R.sup.4)-- (wherein R.sup.4 stands for H or an optionally substituted alkyl group).
REFERENCES:
patent: 5128256 (1992-07-01), Naka et al.
patent: 5196444 (1993-03-01), Naka et al.
patent: 5250554 (1993-10-01), Naka et al.
Kohara et al., "Angiotensin Blockade and the Progression of Renal Damage in the Spontaneously Hypertensive Rat", Hypertension, 21, 6:975-979 (1993).
Honma et al., "Renal protective effects of the angiotensin II(Ang II) receptor antagonist CV-11974 . . . ", JASN, 4:513 (1993).
Bohm et al., "The Angiotensin II Antagonist BIBR277 Normalized Blood Pressure and Improves . . . ", The FASEB Jnl., 7,3:A246 (1993).
Wolf, et al., "Glucose-Induced Hypertrophy in Cultured Proximal Tubule Cells: Enhancement by Angiotensin II (AII)", The FASEB Jnl., 5,5:A1039 (1991).
Dunn, "Prostaglandins, Angiotension II, and Proteinuria", Nephron, 5:30-37 (1990).
Noda et al., "Inhibition of Rabbit Aortic Angiotensin II (AII) Receptor by CV-11974, A New Nonpeptide All Antagonist", Bio, Pharm., 46,2:311-318 (1993).
Kubo Keiji
Nishikawa Kohei
Shibouta Yumiko
Takeda Chemical Industries Ltd.
Weddington Kevin E.
LandOfFree
Prophylactic or therapeutic drug for renal diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prophylactic or therapeutic drug for renal diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prophylactic or therapeutic drug for renal diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1215520